Nano Pharma SRL
Nano Pharma reported total assets of 16,303 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jan 2026).
The score of Nano Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -84 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nano Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −11,159 € | ||||
| Equity | −8,431 € | ||||
| Cash | 11,446 € | ||||
| EBITDA | −10,262 € | ||||
| Total assets | 16,303 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 14 Jan 2026
- Year ended 30 Jun 2024filed on 17 Dec 2024
- Year ended 30 Jun 2023filed on 12 Dec 2023
- Year ended 30 Jun 2022filed on 08 Dec 2022
- Year ended 30 Jun 2021filed on 09 Dec 2021
Nano Pharma's financial analysis
- Solvency-51.7%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nano Pharma
Nano Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0664.843.344
- VAT number
- BE0664843344
- Peppol
- Registered · 0208:0664843344 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Oct 2016
- Registered office
- 1081 Koekelberg
- Latest accounts
- 2025 · filed on 14 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Nano Pharma (SRL) has been based in Koekelberg since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 11,159 € and equity of −8,431 €; its revenue is not published. Its solvency stands at -51.7%, below the median of its sector (37.8%).
Companies similar to Nano Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Arnaud Nicolas Retail sale of pharmaceutical products Ixelles · balance sheet 161,036 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Mathilde Kesteman Retail sale of pharmaceutical products Esneux · balance sheet 40,429 €
- MKR Consulting Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 40,911 €
- Lotte Deroover Retail sale of pharmaceutical products Boortmeerbeek · balance sheet 39,701 €
- HM Pharmaceuticals Retail sale of pharmaceutical products Uccle · balance sheet 57,918 €
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
- MB Pharmaceutics Retail sale of pharmaceutical products Riemst · balance sheet 57,363 €
Frequently asked questions about Nano Pharma
What is the revenue of Nano Pharma?
Nano Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Nano Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0664843344 for Nano Pharma, if the company is VAT-registered. Its company number (CBE) is 0664.843.344.
Where is the registered office of Nano Pharma?
According to the CBE register, the registered office of Nano Pharma is in 1081 Koekelberg.
What is the equity of Nano Pharma?
At the close of the 2025 financial year, the equity of Nano Pharma amounts to -8,431 €, a solvency of -51.7% of total assets.
Who manages Nano Pharma?
The register lists 1 active mandates at Nano Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Nano Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →